股本结构
单位：万股
| 公告日期 | 2024-02-14 | 2024-02-14 | 2023-11-14 | 2023-11-14 | 2023-10-12 | 2023-10-12 |
|---|---|---|---|---|---|---|
| 证券总股本 | 556.76 | 556.73 | 556.75 | 553.02 | 553.00 | 551.72 |
| 普通股本 | 556.76 | 556.73 | 556.75 | 553.02 | 553.00 | 551.72 |
| 优先股 | 未披露 | 未披露 | 未披露 | 未披露 | 未披露 | 未披露 |
| 其他 | 未披露 | 未披露 | 未披露 | 未披露 | 未披露 | 未披露 |
| 变动日期 | 2024-02-01 | 2023-12-31 | 2023-11-01 | 2023-09-30 | 2023-08-31 | 2023-06-30 |
注释：中概股证券总股本=普通股股本/
存托凭证比例
历史变动
| 公告日期 | 变动后普通股本（万股） | 变动后优先股（万股） | 变动原因 | 变动日期 |
|---|---|---|---|---|
| 2024-02-14 | 556.76 | 未披露 | 定期报告 | 2024-02-01 |
| 2024-02-14 | 556.73 | 未披露 |
更多>>
From September 30, 2023 to December 31, 2023
Stock-based compensation expense
Issuance of common stock with exercise of warrants
|
2023-12-31 |
| 2023-11-14 | 556.75 | 未披露 | 定期报告 | 2023-11-01 |
| 2023-11-14 | 553.02 | 未披露 |
更多>>
From July 1, 2023 to September 30, 2023
Stock-based compensation
|
2023-09-30 |
| 2023-10-12 | 553.00 | 未披露 | 定期报告 | 2023-08-31 |
| 2023-10-12 | 551.72 | 未披露 |
更多>>
From June 30, 2022 to June 30, 2023
Stock-based compensation
Issuance of common stock, net of $1,004 issuance cost
|
2023-06-30 |
| 2023-06-12 | 378.02 | 未披露 | 定期报告 | 2023-05-31 |
| 2023-05-11 | 378.02 | 未披露 | 定期报告 | 2023-05-08 |
| 2023-05-11 | 377.95 | 未披露 |
更多>>
From December 31, 2022 to March 31, 2023
Issuance of common stock, net of issuance cost
Stock-based compensation
|
2023-03-31 |
| 2023-04-07 | 377.87 | 未披露 | 定期报告 | 2023-03-24 |
| 2023-02-21 | 357.33 | 未披露 | 定期报告 | 2023-02-14 |
| 2023-01-05 | 340.00 | 未披露 |
更多>>
Aytu BioPharma Announces 1-for-20 Reverse Stock Split.
|
2023-01-06 |
| 2023-01-05 | 6880.00 | 未披露 | 定期报告 | 2023-01-05 |
| 2022-11-14 | 6242.94 | 未披露 | 定期报告 | 2022-11-09 |
| 2022-11-14 | 5930.00 | 未披露 | 定期报告 | 2022-11-03 |
| 2022-08-15 | 6243.27 | 未披露 |
更多>>
1.Common stock offered by 21,505,814 shares of common stock
2.The number of common stock to be outstanding after this offering is based on 39,176,913 shares of common stock outstanding as of August 1, 2022
3.The pre-funded warrants to purchase 1,750,000 shares of its common stock were exercised in full on August 11, 2022
|
2022-08-11 |
| 2022-08-08 | 3917.69 | 未披露 | 定期报告 | 2022-08-01 |
| 2022-09-27 | 3857.88 | 未披露 |
更多>>
From June 30, 2021 to June 30, 2022
Stock-based compensation
Issuance of common stock, net of 1,048,000 issuance cost
Issuance of common stock related to milestone payment
|
2022-06-30 |
| 2022-06-08 | 3857.49 | 未披露 | 定期报告 | 2022-06-03 |
| 2022-05-16 | 3857.49 | 未披露 | 定期报告 | 2022-05-09 |
| 2022-05-16 | 3335.59 | 未披露 |
更多>>
From June 30, 2021 to March 31, 2022
Stock-based compensation
Issuance of common stock, net of issuance cost
|
2022-03-31 |
| 2022-04-07 | 3335.59 | 未披露 | 定期报告 | 2022-03-25 |
| 2022-02-14 | 3031.82 | 未披露 | 定期报告 | 2022-02-07 |
| 2022-02-14 | 3001.05 | 未披露 |
更多>>
From September 30, 2021 to December 31, 2021
Stock-based compensation
Issuance of common stock, net of issuance cost
Issuance of common stock related to debt conversion
|
2021-12-31 |
| 2021-11-15 | 2814.77 | 未披露 | 定期报告 | 2021-11-05 |
| 2021-11-15 | 2777.19 | 未披露 |
更多>>
From June 30, 2021 to September 30, 2021
Stock-based compensation
Issuance of common stock, net of issuance cost
|
2021-09-30 |
| 2021-09-28 | 2755.19 | 未披露 | 定期报告 | 2021-09-20 |
| 2021-09-28 | 2755.51 | 未披露 | 定期报告 | 2021-09-10 |
| 2021-09-28 | 2749.04 | 未披露 |
更多>>
From June 30, 2020 to June 30, 2021
Stock-based compensation
Issuance of stock for business acquisition, net of issuance costs
Issuance of common stock from 2020 Shelf, net of $731 and $1,860 issuance costs in 2021 and 2020, respectively
Issuance of common stock related to debt conversion
Issuance of common stock from December 2020 offering, net of $2,640 issuance costs
Issuance of common stock for CVRs payout
|
2021-06-30 |
| 2021-05-17 | 2517.06 | 未披露 | 定期报告 | 2021-05-10 |
| 2021-04-19 | 2347.30 | 未披露 | 定期报告 | 2021-04-16 |
| 2021-05-17 | 2345.79 | 未披露 |
更多>>
From December 31, 2020 To March 31, 2021
Issuance of common stock due to acquisition, net of $137,735 in costs
CVR payouts
|
2021-03-31 |
| 2021-02-11 | 1788.29 | 未披露 |
更多>>
From December 31, 2019 to December 31, 2020
Exchange of debt for common stock
Issuance of common stock, net of issue costs and warrants
|
2020-12-31 |
| 2021-01-27 | 1788.29 | 未披露 |
更多>>
1.Common stock offered by the company 4,166,667 Shares.
2.Unless otherwise indicated, the number of common stock to be outstanding after this offering is based on approximately 13,079,675 common stock outstanding as of December 10, 2020.
|
2020-12-15 |
| 2020-12-14 | 1307.97 | 未披露 | 定期报告 | 2020-12-10 |
| 2020-12-08 | 1294.96 | 未披露 |
更多>>
Immediately after the reverse split becomes effective, there will be approximately 12,949,570 million shares of common stock issued and outstanding. The common shares will trade under a new CUSIP number, 054754874, effective December 9, 2020, and continue to trade under the symbol “AYTU.” All stock options and warrants of the Company outstanding immediately prior to the reverse stock split have been proportionally adjusted.
|
2020-12-09 |
| 2020-11-12 | 12792.85 | 未披露 | 定期报告 | 2020-11-01 |
| 2020-10-06 | 12583.74 | 未披露 |
更多>>
From June 30, 2019 to June 30, 2020
Issuance of Series H preferred stock and common stock due to acquisition of Innovus
Issuance of Series F preferred stock from October 2019 private placement financing, net of $741,650 issuance costs
Preferred converted into common stock
Issuance of Series G preferred stock due to acquisition of Cerecor
Stock-based compensation
Issuance of common stock, net of $4,523,884 in cash issuance costs
Issuance of common stock, net of $1,860,194 in issuance costs
Issuance of common stock related to debt conversion
Cashless warrant exercise
Warrant and option exercises
Common stock issued to consultants
Issuance of common stock related to settlement
CVR payouts
|
2020-06-30 |
| 2020-06-08 | 12061.49 | 未披露 | 定期报告 | 2020-06-01 |
| 2020-05-15 | 12026.14 | 未披露 | 定期报告 | 2020-05-01 |
| 2020-05-15 | 10061.04 | 980.58 |
更多>>
From December 31, 2019 to March 31, 2020
Issuance of Series H preferred stock and common stock due to acquisition of
Innovus
Preferred stock converted in common stock
Stock-based compensation
Cashless warrant exercise
Warrant exercises
Issuance of common stock, net of $4,523,884 in cash issuance costs
CVR payouts
|
2020-03-31 |
| 2020-03-04 | 2930.71 | 未披露 | 定期报告 | 2020-03-03 |
| 2020-02-28 | 2782.85 | 240.79 | 定期报告 | 2020-02-28 |
| 2020-03-04 | 2782.83 | 未披露 | 定期报告 | 2020-02-25 |
| 2020-02-24 | 2682.85 | 未披露 | 定期报告 | 2020-02-14 |
| 2020-02-14 | 2301.81 | 未披露 | 定期报告 | 2020-02-01 |
| 2020-02-14 | 2073.31 | 1021.58 |
更多>>
from September 30, 2019 to December 31, 2019
Issuance of Series F preferred stock from October 2019 private placement financing, net of $741,650 issuance costs (unaudited)
Issuance of Series G preferred stock due to acquisition of the Cerecor portfolio of pediatrics therapeutics (unaudited)
Preferred stock converted in common stock (unaudited)
|
2019-12-31 |
| 2019-11-14 | 2073.31 | 未披露 | 定期报告 | 2019-11-01 |
| 2019-11-14 | 1798.11 | 315.11 |
更多>>
From June 30, 2019 to September 30, 2019
Preferred stock converted in common stock
|
2019-09-30 |
| 2019-09-26 | 1768.81 | 未披露 | 定期报告 | 2019-08-31 |
| 2019-09-26 | 1753.81 | 359.50 |
更多>>
From June 30, 2018 to June 30, 2019
Stock-based compensation
Common stock issued to employee
Issuance of preferred, common stock and warrants, net of $1,479,963 in cash issuance costs
Preferred stock converted into common stock
Issuance of preferred stock
Issuance of preferred, common stock related to debt conversion
Warrants exercised
Rounding from reverse stock split
|
2019-06-30 |
| 2019-05-14 | 1666.04 | 未披露 | 定期报告 | 2019-05-01 |
| 2019-05-14 | 1284.85 | 233.57 |
更多>>
From December 31, 2018 to March 31, 2019
Issuance of restricted stock (unaudited)
Preferred stocks converted into common stock (unaudited)
Warrant exercises (unaudited)
|
2019-03-31 |
| 2019-02-25 | 1245.54 | 未披露 | 定期报告 | 2019-02-14 |
| 2019-02-07 | 1239.04 | 未披露 | 定期报告 | 2019-02-06 |
| 2019-02-07 | 1050.48 | 453.27 |
更多>>
From June 30, 2018 to December 31, 2018
Adjustment for rounding of shares due to stock split
Issuance of preferred and common stock, net of $1,479,963 in cash issuance costs
Preferred stocks issued in connection with the purchase of assets
Preferred stocks converted into common stock
|
2018-12-31 |
| 2018-11-07 | 863.41 | 未披露 | 定期报告 | 2018-11-01 |
| 2018-11-07 | 180.14 | 未披露 |
更多>>
From June 30, 2018 to August 31, 2018
Adjustment for rounding of shares due to stock split
|
2018-08-31 |
| 2018-09-06 | 179.48 | 未披露 |
更多>>
From June 30, 2017 to Auguest 13, 2018
Issuance of preferred and common stock, net of $1,402,831 in cash issuance costs
Issuance of preferred and common stock, net of $1,294,235 in cash issuance costs
Preferred stock converted in common stock
Issuance of restricted stock
Earn-out payment to Nuelle shareholders
Warrant exercises
Adjustment for rounding of shares due to stock split
The reverse stock split will reduce the number of shares of outstanding common stock from approximately 35.9 million shares to approximately 1.8 million shares.
|
2018-08-13 |
| 2018-05-09 | 3588.31 | 未披露 | 定期报告 | 2018-05-03 |
| 2018-05-14 | 3588.81 | 未披露 | 定期报告 | 2018-05-01 |
| 2018-05-14 | 3582.01 | 未披露 |
更多>>
From June 30, 2017 to March 31, 2018
Issuance of preferred and common stock, net of $1,402,831 in cash issuance costs (unaudited)
Issuance of preferred stock and common stock, net of $1,294,235 in cash issuance costs (unaudited)
Preferred stocks converted in common stock (unaudited)
Issuance of restricted stock (unaudited)
Earn-out payment to Nuelle shareholders (unaudited)
Warrant exercises (unaudited)
|
2018-03-31 |
| 2018-02-08 | 496.96 | 未披露 | 定期报告 | 2018-02-01 |
| 2018-02-08 | 489.46 | 0.19 |
更多>>
From June 30, 2017 to December 31, 2017
Issuance of restricted stock
Earn-out payment to Nuelle shareholders
Issuance of preferred and common stock, net of $1,402,831 in cash issuance costs
Preferred stocks converted in common stock
Adjustment for rounding of shares due to stock split
|
2017-12-31 |
| 2017-11-22 | 489.76 | 0.19 | 定期报告 | 2017-11-21 |
| 2017-11-09 | 440.26 | 未披露 | 定期报告 | 2017-11-01 |
| 2017-10-20 | 1083.65 | 未披露 |
更多>>
Common stock offered by the selling stockholders 9,844,684 shares
|
2017-10-20 |
| 2017-11-09 | 422.48 | 0.23 |
更多>>
From June 30, 2017 to September 21, 2017
Issuance of restricted stock
Earn-out payment to Nuelle shareholders
Issuance of preferred and common stock, net of $1,402,831 in cash issuance costs
Adjustment for rounding of shares due to stock split
|
2017-09-21 |
| 2017-09-05 | 402.18 | 0.23 |
更多>>
On August 11, 2017, we entered into a Securities Purchase Agreement with various investors pursuant to which we agreed to sell Class A and Class B equity units for gross proceeds of approximately $11.8 million. Giving effect to the 1-for-20 reverse stock split effected on August 25, 2017, Class A units consist of one twentieth (1/20) of a share of common stock and a warrant to purchase three-fortieths (3/40) of a share of common stock and were sold at a negotiated price of $3.00 per unit. Class B units consist of one (1) share of our newly created Series A Preferred Stock, and warrants to purchase three-fortieths (3/40) of a share of common stock for each share of common stock into which the Series A Preferred Stock is convertible and were sold at a negotiated price of $1,000 per unit to those purchasers who, together with their affiliates and certain related parties, would beneficially own more than 9.99% of our outstanding common stock following the offering. The offering closed on August 15, 2017.
|
2017-08-31 |
| 2017-08-31 | 82.48 | 未披露 |
更多>>
From June 30, 2016 to August 25, 2017
Lincoln Park stock issuance, net of issuance costs $90,924
Issuance of restricted stock
Common stock issued to executives
Issuance of common stock, net of $997,865 in issuance costs
Warrants issued in connection with registered offering
Warrant tender offer, net of $312,159 in issuance costs
Investment in Subsidiary
On July 26, 2017, our shareholders approved an amendment to our Certificate of Incorporation to affect a reverse stock split at a ratio of 1-for-20 which became effective on August 25, 2017.
|
2017-08-25 |
| 2017-06-16 | 1642.66 | 未披露 | 定期报告 | 2017-05-05 |
| 2017-05-11 | 1383.66 | 未披露 |
更多>>
from June 30, 2016 to March 31, 2017
Lincoln Park Capital stock issuance, net of $24,247 in issuance costs
Issuance of restricted stock
Common stock issued to executives
Issuance of common stock, net of $997,865 in cash issuance costs
Warrant tender offer, net of $332,567 in issuance costs
|
2017-03-31 |
| 2017-02-09 | 1084.56 | 未披露 |
更多>>
from June 30, 2016 to December 31, 2016
Lincoln Park Capital stock issuance, net of $24,247 in issuance costs(unaudited)
Issuance of restricted stock (unaudited)
Common stock issued to executives (unaudited)
Issuance of common stock, net of $997,865 in cash issuance costs (unaudited)
|
2016-12-31 |
| 2016-11-07 | 1084.56 | 未披露 |
更多>>
On October 27, 2016, we priced an underwritten public offering of 5,735,000 shares of its common stock and warrants to purchase up to an aggregate of 5,735,000 shares of its common stock at a combined public offering price of $1.50 per share and related warrant.
|
2016-11-03 |
| 2016-11-07 | 511.06 | 未披露 |
更多>>
from June 30, 2016 to September 30, 2016
Lincoln Park Capital stock issuance, net of issuance costs of $24,247 (unaudited)
Issuance of restricted stock (unaudited)
Common stock issued to executives (unaudited)
|
2016-09-30 |
| 2016-10-05 | 508.06 | 未披露 | 定期报告 | 2016-09-22 |
| 2016-09-02 | 507.06 | 未披露 | 定期报告 | 2016-08-15 |
| 2016-09-02 | 374.19 | 未披露 |
更多>>
From June 30, 2015 to June 30, 2016
Stock subscription
Conversion of convertible promissory notes and interest to common stock, net of $29,754 conversion costs
Issuance of common stock, net of $1,202,231 in issuance costs
Adjustment for rounding of shares due to stock split
|
2016-06-30 |
From September 30, 2023 to December 31, 2023
Stock-based compensation expense
Issuance of common stock with exercise of warrants
From July 1, 2023 to September 30, 2023
Stock-based compensation
From June 30, 2022 to June 30, 2023
Stock-based compensation
Issuance of common stock, net of $1,004 issuance cost
From December 31, 2022 to March 31, 2023
Issuance of common stock, net of issuance cost
Stock-based compensation
Aytu BioPharma Announces 1-for-20 Reverse Stock Split.
1.Common stock offered by 21,505,814 shares of common stock
2.The number of common stock to be outstanding after this offering is based on 39,176,913 shares of common stock outstanding as of August 1, 2022
3.The pre-funded warrants to purchase 1,750,000 shares of its common stock were exercised in full on August 11, 2022
From June 30, 2021 to June 30, 2022
Stock-based compensation
Issuance of common stock, net of 1,048,000 issuance cost
Issuance of common stock related to milestone payment
From June 30, 2021 to March 31, 2022
Stock-based compensation
Issuance of common stock, net of issuance cost
From September 30, 2021 to December 31, 2021
Stock-based compensation
Issuance of common stock, net of issuance cost
Issuance of common stock related to debt conversion
From June 30, 2021 to September 30, 2021
Stock-based compensation
Issuance of common stock, net of issuance cost
From June 30, 2020 to June 30, 2021
Stock-based compensation
Issuance of stock for business acquisition, net of issuance costs
Issuance of common stock from 2020 Shelf, net of $731 and $1,860 issuance costs in 2021 and 2020, respectively
Issuance of common stock related to debt conversion
Issuance of common stock from December 2020 offering, net of $2,640 issuance costs
Issuance of common stock for CVRs payout
From December 31, 2020 To March 31, 2021
Issuance of common stock due to acquisition, net of $137,735 in costs
CVR payouts
From December 31, 2019 to December 31, 2020
Exchange of debt for common stock
Issuance of common stock, net of issue costs and warrants
1.Common stock offered by the company 4,166,667 Shares.
2.Unless otherwise indicated, the number of common stock to be outstanding after this offering is based on approximately 13,079,675 common stock outstanding as of December 10, 2020.
Immediately after the reverse split becomes effective, there will be approximately 12,949,570 million shares of common stock issued and outstanding. The common shares will trade under a new CUSIP number, 054754874, effective December 9, 2020, and continue to trade under the symbol “AYTU.” All stock options and warrants of the Company outstanding immediately prior to the reverse stock split have been proportionally adjusted.
From June 30, 2019 to June 30, 2020
Issuance of Series H preferred stock and common stock due to acquisition of Innovus
Issuance of Series F preferred stock from October 2019 private placement financing, net of $741,650 issuance costs
Preferred converted into common stock
Issuance of Series G preferred stock due to acquisition of Cerecor
Stock-based compensation
Issuance of common stock, net of $4,523,884 in cash issuance costs
Issuance of common stock, net of $1,860,194 in issuance costs
Issuance of common stock related to debt conversion
Cashless warrant exercise
Warrant and option exercises
Common stock issued to consultants
Issuance of common stock related to settlement
CVR payouts
From December 31, 2019 to March 31, 2020
Issuance of Series H preferred stock and common stock due to acquisition of
Innovus
Preferred stock converted in common stock
Stock-based compensation
Cashless warrant exercise
Warrant exercises
Issuance of common stock, net of $4,523,884 in cash issuance costs
CVR payouts
from September 30, 2019 to December 31, 2019
Issuance of Series F preferred stock from October 2019 private placement financing, net of $741,650 issuance costs (unaudited)
Issuance of Series G preferred stock due to acquisition of the Cerecor portfolio of pediatrics therapeutics (unaudited)
Preferred stock converted in common stock (unaudited)
From June 30, 2019 to September 30, 2019
Preferred stock converted in common stock
From June 30, 2018 to June 30, 2019
Stock-based compensation
Common stock issued to employee
Issuance of preferred, common stock and warrants, net of $1,479,963 in cash issuance costs
Preferred stock converted into common stock
Issuance of preferred stock
Issuance of preferred, common stock related to debt conversion
Warrants exercised
Rounding from reverse stock split
From December 31, 2018 to March 31, 2019
Issuance of restricted stock (unaudited)
Preferred stocks converted into common stock (unaudited)
Warrant exercises (unaudited)
From June 30, 2018 to December 31, 2018
Adjustment for rounding of shares due to stock split
Issuance of preferred and common stock, net of $1,479,963 in cash issuance costs
Preferred stocks issued in connection with the purchase of assets
Preferred stocks converted into common stock
From June 30, 2018 to August 31, 2018
Adjustment for rounding of shares due to stock split
From June 30, 2017 to Auguest 13, 2018
Issuance of preferred and common stock, net of $1,402,831 in cash issuance costs
Issuance of preferred and common stock, net of $1,294,235 in cash issuance costs
Preferred stock converted in common stock
Issuance of restricted stock
Earn-out payment to Nuelle shareholders
Warrant exercises
Adjustment for rounding of shares due to stock split
The reverse stock split will reduce the number of shares of outstanding common stock from approximately 35.9 million shares to approximately 1.8 million shares.
From June 30, 2017 to March 31, 2018
Issuance of preferred and common stock, net of $1,402,831 in cash issuance costs (unaudited)
Issuance of preferred stock and common stock, net of $1,294,235 in cash issuance costs (unaudited)
Preferred stocks converted in common stock (unaudited)
Issuance of restricted stock (unaudited)
Earn-out payment to Nuelle shareholders (unaudited)
Warrant exercises (unaudited)
From June 30, 2017 to December 31, 2017
Issuance of restricted stock
Earn-out payment to Nuelle shareholders
Issuance of preferred and common stock, net of $1,402,831 in cash issuance costs
Preferred stocks converted in common stock
Adjustment for rounding of shares due to stock split
Common stock offered by the selling stockholders 9,844,684 shares
From June 30, 2017 to September 21, 2017
Issuance of restricted stock
Earn-out payment to Nuelle shareholders
Issuance of preferred and common stock, net of $1,402,831 in cash issuance costs
Adjustment for rounding of shares due to stock split
On August 11, 2017, we entered into a Securities Purchase Agreement with various investors pursuant to which we agreed to sell Class A and Class B equity units for gross proceeds of approximately $11.8 million. Giving effect to the 1-for-20 reverse stock split effected on August 25, 2017, Class A units consist of one twentieth (1/20) of a share of common stock and a warrant to purchase three-fortieths (3/40) of a share of common stock and were sold at a negotiated price of $3.00 per unit. Class B units consist of one (1) share of our newly created Series A Preferred Stock, and warrants to purchase three-fortieths (3/40) of a share of common stock for each share of common stock into which the Series A Preferred Stock is convertible and were sold at a negotiated price of $1,000 per unit to those purchasers who, together with their affiliates and certain related parties, would beneficially own more than 9.99% of our outstanding common stock following the offering. The offering closed on August 15, 2017.
From June 30, 2016 to August 25, 2017
Lincoln Park stock issuance, net of issuance costs $90,924
Issuance of restricted stock
Common stock issued to executives
Issuance of common stock, net of $997,865 in issuance costs
Warrants issued in connection with registered offering
Warrant tender offer, net of $312,159 in issuance costs
Investment in Subsidiary
On July 26, 2017, our shareholders approved an amendment to our Certificate of Incorporation to affect a reverse stock split at a ratio of 1-for-20 which became effective on August 25, 2017.
from June 30, 2016 to March 31, 2017
Lincoln Park Capital stock issuance, net of $24,247 in issuance costs
Issuance of restricted stock
Common stock issued to executives
Issuance of common stock, net of $997,865 in cash issuance costs
Warrant tender offer, net of $332,567 in issuance costs
from June 30, 2016 to December 31, 2016
Lincoln Park Capital stock issuance, net of $24,247 in issuance costs(unaudited)
Issuance of restricted stock (unaudited)
Common stock issued to executives (unaudited)
Issuance of common stock, net of $997,865 in cash issuance costs (unaudited)
On October 27, 2016, we priced an underwritten public offering of 5,735,000 shares of its common stock and warrants to purchase up to an aggregate of 5,735,000 shares of its common stock at a combined public offering price of $1.50 per share and related warrant.
from June 30, 2016 to September 30, 2016
Lincoln Park Capital stock issuance, net of issuance costs of $24,247 (unaudited)
Issuance of restricted stock (unaudited)
Common stock issued to executives (unaudited)
From June 30, 2015 to June 30, 2016
Stock subscription
Conversion of convertible promissory notes and interest to common stock, net of $29,754 conversion costs
Issuance of common stock, net of $1,202,231 in issuance costs
Adjustment for rounding of shares due to stock split